Result of AGM

Summary by AI BETAClose X

MicroSalt Plc announced that all resolutions presented at its Annual General Meeting were passed by shareholders. Ordinary resolutions for the approval of the Annual Report and Accounts, the re-appointment of Crowe U.K. LLP as auditors, and the authorization for directors to set auditor remuneration all received overwhelming support, with approximately 99.90% of votes cast in favour. Resolutions to re-elect directors Judith Batchelar, Rick Guiney, Gary Urmston, and Daniel Emery also passed with strong majorities, ranging from 98.68% to 99.90% in favour. The special resolution to disapply pre-emption rights was also approved with 97.66% of votes in favour. The total number of shares in issue as of 30 June 2026 was 55,911,374.

Disclaimer*

MicroSalt PLC
01 July 2026
 

1 July 2026

MicroSalt Plc

("MicroSalt" or the "Company")

Result of AGM

MicroSalt (AIM: SALT), a leading manufacturer of full-flavour natural salt with approximately 50% less sodium, is pleased to announce that all resolutions proposed to shareholders at its Annual General Meeting were duly passed.

The total number of votes received in respect of all resolutions were as follows:

 

For

Against

Votes Withheld

Total votes cast

Number of Votes

%

Number of Votes

%

Ordinary Resolutions

1. Approval of Annual Report and Accounts

34,766,508

99.90%

33,980

0.10%

54

34,800,488

2. To re-appointment Crowe U.K. LLP as Auditors

34,760,383

99.90%

35,073

0.10%

5,086

34,795,456

3. To authorise Directors to set Auditors remuneration

34,758,383

99.90%

35,073

0.10%

7,086

34,793,456

4. To re-elect Judith Batchelar as a Director

34,336,743

98.69%

456,713

1.31%

7,086

34,793,456

5. To re-elect Rick Guiney as a Director

34,336,143

99.90%

35,695

0.10%

428,704

34,371,838

6. To re-elect Gary Urmston as a Director

34,336,143

98.69%

457,313

1.31%

7,086

34,793,456

7. To re-elect Daniel Emery as a Director

34,334,744

98.68%

458,712

1.32%

7,086

34,793,456

8. Authority to Allot Shares

34,309,399

98.62%

480,268

1.38%

10,875

34,789,667

Special Resolution

9. Disapplication of pre-emption rights

33,972,529

97.66%

815,139

2.34%

12,874

34,787,668









 

Notes:

1.   Proxy appointments which gave discretion to the Chairman of the AGM have been included in the "For" total for the appropriate resolution.

2.   Votes "For" and "Against" any resolution are expressed as a percentage of votes validly cast for that resolution.

3.   A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against".

4.   The number of shares in issue on 30 June 2026 was 55,911,374.

5.   The full text of the resolutions passed at the AGM can be found in the Notice of Annual General Meeting which is available on the Company's website at http://www.microsaltinc.com/.

For more information, please visit https://microsaltinc.com, follow on X @MicroSaltPLC or contact:

 

MicroSalt plc

Via Gracechurch Group

Rick Guiney, CEO 

 




Zeus (Nominated adviser and broker)




David Foreman / James Edis (Investment Banking)

+44 (0)20 3829 5000

 


Gracechurch Group (Financial PR) 

+44 (0)20 4582 3500

Heather Armstrong, Alexis Gore, Rebecca Scott


 

About MicroSalt

MicroSalt® produces a patented full-flavour, low-sodium salt for food manufacturers and consumers.

MicroSalt is a major potential disruptor in the food market, thanks to its micron sized particles which deliver the same sense of saltiness to a wide range of foods but with approximately 50% less sodium. Excess sodium consumption is a significant contributor to cardiovascular disease and MicroSalt's solution meets the rising demand for healthier alternatives to traditional salt. The WHO has set a target for reducing global sodium intake by 30% by 2025, which it estimates will save 7 million lives by 2030.

Each year, cardiovascular disease costs the UK £19 billion - if the average salt intake was reduced by one gram per day, it has been estimated that 4,147 lives and £288 million would be saved each year in the UK. As a nation, the UK consumes 183 million kilograms of salt each year, and 70% of the typical person's sodium intake is hidden in processed foods.

Operational since 2018, MicroSalt uses a patent-protected technology which helps create high barriers to entry within the reduced-sodium salt market.

The Directors believe that MicroSalt is well positioned to capture growth in the low sodium market, which is expected to grow exponentially, and that there is also scope to enter the larger salt market.

MicroSalt is ideally positioned for scale and market leadership, with clear pathways into food manufacturing, consumer channels, and ultimately the broader £10+ billion global salt market. MicroSalt is more than a healthier alternative-it is a disruptive, category-defining solution poised to deliver significant commercial and societal impact.

For more information, please visit www.microsaltinc.com or follow on X @microSaltPLC.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Microsalt (SALT)
UK 100

Latest directors dealings